Nanoparticles induce autophagy via mTOR pathway inhibition and reactive oxygen species generation.

Nanomedicine
Lu JiaWan-Xi Yang

Abstract

Due to their unique physicochemical properties, nanoparticles (NPs) have been increasingly developed for use in various fields. However, there has been both growing negative concerns with toxicity and positive realization of opportunities in nanomedicine, coming from the growing understanding of the associations between NPs and the human body, particularly relating to their cellular autophagic effects. This review summarizes NP-induced autophagy via the modulation of the mTOR signaling pathway and other associated signals including AMPK and ERK and also demonstrates how reactive oxygen species generation greatly underlies the regulation processes. The perspectives in this review aim to contribute to NP design, particularly in consideration of nanotoxicity and the potential for the precise application of NPs in nanomedicine.

References

Mar 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·P O Seglen, P B Gordon
Jun 1, 1997·The EMBO Journal·H B JefferiesG Thomas
Feb 13, 2002·Cell Death and Differentiation·M CastedoG Kroemer
May 26, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Helene PelicanoPeng Huang
Nov 6, 2004·Science·Ichiro NakagawaTamotsu Yoshimori
Sep 24, 2005·Cell·Sophie PattingreBeth Levine
Aug 4, 2006·The Journal of Clinical Investigation·Lucile EspertMartine Biard-Piechaczyk
Sep 14, 2006·Annual Review of Pharmacology and Toxicology·Thomas W KenslerShyam Biswal
Sep 19, 2006·The International Journal of Biochemistry & Cell Biology·Marian ValkoJoshua Telser
Jan 9, 2007·Current Biology : CB·Ryan C ScottThomas P Neufeld
Mar 14, 2007·Autophagy·Olga ZabirnykOleksandr Seleverstov
Jun 21, 2007·The Journal of Biological Chemistry·Serhiy PankivTerje Johansen
Jul 7, 2007·Cancer Cell·David A Guertin, David M Sabatini
Sep 7, 2007·Trends in Cell Biology·Ruth Scherz-Shouval, Zvulun Elazar
Oct 3, 2007·Nature Cell Biology·Zhiping Xie, Daniel J Klionsky
Feb 29, 2008·Nature·Noboru MizushimaDaniel J Klionsky
Dec 9, 2008·The Biochemical Journal·Michael P Murphy
Feb 13, 2009·Molecular Biology of the Cell·Nao HosokawaNoboru Mizushima
Feb 25, 2009·ACS Nano·P V AshaRaniSuresh Valiyaveettil
May 2, 2009·Cell Death and Differentiation·Y ChenS B Gibson
Jun 3, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sao JiralerspongAna M Gonzalez-Angulo
Jul 31, 2009·Oncogene·S Sinha, B Levine
Dec 8, 2009·Trends in Neurosciences·Charles A Hoeffer, Eric Klann
Jan 20, 2010·FEBS Letters·Chang Hwa JungDo-Hyung Kim
Feb 11, 2010·Cell·Noboru MizushimaBeth Levine
Feb 16, 2010·FEBS Letters·Masaaki Komatsu, Yoshinobu Ichimura
Mar 13, 2010·The Journal of Pathology·Sandra BarthKay F Macleod
Oct 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Zhi-Hua ChenAugustine M K Choi
Oct 21, 2010·Physiological Reviews·Brinda RavikumarDavid C Rubinsztein
Nov 5, 2010·The Journal of Investigative Dermatology·Johannes WerzowaVolker Wacheck
Dec 4, 2010·Particle and Fibre Toxicology·Dorota NapierskaPeter H Hoet
Dec 16, 2010·Nature Reviews. Molecular Cell Biology·Roberto ZoncuDavid M Sabatini
Jun 28, 2011·Nanomedicine : Nanotechnology, Biology, and Medicine·Suphiya ParveenSanjeeb K Sahoo

❮ Previous
Next ❯

Citations

Jul 6, 2021·Drug Discovery Today·Bartlomiej Szabat-Iriaka, Marc Le Borgne

❮ Previous
Next ❯

Methods Mentioned

BETA
oncotherapy

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms